It is a healthcare private limited company based in Navi Mumbai, Maharashtra, India, established in 2016.
2016 | Navi Mumbai, Maharashtra, India | ActiveInnovativ Biosciences Private Limited, a active private limited company, was established on 28 April 2016 in Navi Mumbai, Maharashtra, India. Engaging in medical consumables & supplies within the healthcare sector, it holds CIN: U52601MH2016PTC280289. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shraddha Rupesh Yeola (Director), Rupesh Ratnakar Yeola (Director). Past directors included Kuldeep Raghunath Bagad. It holds ₹0.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sai Mauli Hospital, Plot No 107, Sector 1 Ghansoli, Navi Mumbai, Maharashtra, 400701.
U52601MH2016PTC280289
280289
28 April 2016
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Innovativ Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shraddha Rupesh Yeola | Director | 21 Dec 2017 | Current |
| Rupesh Ratnakar Yeola | Director | 28 Apr 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Innovativ Biosciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Innovativ Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹600,500.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2021 | Others | ₹0.60 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Innovativ Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Innovativ Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovativ Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Innovativ Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Innovativ Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.60 M with Charge ID 100468383 was registered on 27 Jul 2021. was documented.
Progress on Shraddha Rupesh Yeola was appointed as a Director was appointed as a Director on 21 Dec 2017 & has been associated with this company since 8 years 7 days . was documented.
Progress on Rupesh Ratnakar Yeola was appointed as a Director was appointed as a Director on 28 Apr 2016 & has been associated with this company since 9 years 8 months . was documented.
Progress on Innovativ Biosciences Private Limited was registered on 28 Apr 2016 with Roc Mumbai & aged 9 years 8 months as per MCA records. was documented.
The CIN of Innovativ Biosciences Private Limited is U52601MH2016PTC280289.
Innovativ Biosciences Private Limited is headquartered at Sai Mauli Hospital, Plot No 107, Sector 1 Ghansoli, Navi Mumbai, Maharashtra, 400701.
Innovativ Biosciences Private Limited was incorporated on 28 April 2016.
The current directors of Innovativ Biosciences Private Limited are
The primary industry of Innovativ Biosciences Private Limited is Healthcare.
Innovativ Biosciences Private Limited is unlisted.
The authorized capital of Innovativ Biosciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Innovativ Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX